Skip to content
Home/Companies/MedTech/Biosency
Biosency

Biosency

MedTech·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Biosency?

Biosency is a French MedTech company, currently owned by Go Capital since 2023.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Go Capital
Investor
Go Capital
Fonds GOCAPITAL Amorçage 2 · 2003 · VC

Key facts

HQFrance
SectorMedTech
Websitebiosency.com

More from Fonds GOCAPITAL Amorçage 2

Other portfolio companies in the same fund.

Flexikeg
Flexikeg
Active
IndustrialsFrance· 2022
Healshape
Healshape
Active
HealthcareFrance· 2022
Aurora Cold Plasma Sterilisation
Aurora Cold Plasma Sterilisation
Active
HealthcareFrance· 2021
Kalsiom
Kalsiom
Exited 2025
BiotechFrance· 2020
Green Impulse
Green Impulse
Active
EnergyFrance· 2019
Turbotech
Turbotech
Exited 2025
Aerospace & DefenceFrance· 2018
to Innovacom

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Biosency?

Biosency is currently owned by Go Capital, through Fonds GOCAPITAL Amorçage 2, since 2023.

When did Go Capital acquire Biosency?

Go Capital acquired Biosency in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue